2025 Annual Meeting, Iowa Radiological Society: Cardiothoracic Radiology

Saturday, November 1, 2025, 7:30 AM - 1:00 PM, Medical Education Research Facility (MERF), Iowa City, IA

The 2025 Annual Meeting of Iowa Radiological Society will explore imaging in Chest and Cardiovascular pathologies, as well as regulatory landscape for radiologists with local and national experts.

Location and Parking
Medical Education Research Facility (MERF)
Room 1110 Prem Sahai Auditorium
375 Newton Road, Iowa City

Building Entrance:  To enter MERF use the West Atrium Entrance. Follow the sidewalk on the west side of the building to the set of doors located at the top of the hill. The conference registration desk will be inside these doors.

Parking is available at prevailing rates in the Newton Road Ramp, located at 360 Newton Road, across the street from the Medical Education and Research Facility.  

AMA PRA Category 1 Credits™ (3.75 hours), Non-Physician Attendance (3.75 hours)

1. Discuss the Importance of Lung cancer Staging – Explain why accurate staging is critical for prognosis and treatment planning.
2. Describe the TNM Classification System – Define the Tumor (T), Node (N), and Metastasis (M) components used in staging lung cancer.
3. Identify Different Stages of Lung Cancer – Differentiate between stages (I-IV) and their clinical significance.
4. Review Staging Modalities – Discuss imaging techniques (CT, PET-CT, MRI) and procedures (bronchoscopy, EBUS, mediastinoscopy) used for staging.
5. Explain Recommended Screening Methods – Describe the role of low-dose computed tomography (LDCT) in early detection.
6. Review Current Screening Guidelines – Discuss national and international guidelines for lung cancer screening (e.g., USPSTF, NCCN).
7. Promote Early Detection and Patient Education – Explore strategies for increasing screening participation and improving patient awareness.
8. Differentiate ILD from other pulmonary conditions based on clinical, radiologic, and histopathologic features.
9. Describe the clinical presentation of ILD, including symptoms, history, and physical exam findings. Review diagnostic tools, including: High-Resolution CT (HRCT) patterns and their significance
10. Identify major ILD subtypes, including Idiopathic Pulmonary Fibrosis (IPF), Connective Tissue Disease-Associated ILD (CTD-ILD), Hypersensitivity Pneumonitis (HP), Sarcoidosis, and others.
11. Explain factors affecting prognosis and disease progression.
12. Review strategies for monitoring ILD progression and response to treatment.

Physician, Non-member: $180
Physician Member, Iowa Radiological Society: $150
Physician UI Dept of Radiology: $150
Alumni UI Dept of Radiology: $150
Radiology Technologist: $85
Fellow/Resident/Student: No Charge

Cancellation Policy
A $25 fee will be charged for cancelled registrations.  No refunds will be given for cancellations made after October 24, 2025.

In support of improving patient care, this activity has been planned and implemented by the University of Iowa Roy J. and Lucille A. Carver College of Medicine and the Iowa Radiological Society. The University of Iowa Roy J. and Lucille A. Carver College of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 Physician:  The University of Iowa Carver College of Medicine designates this live activity for a maximum of 3.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.  

Other Health Care Provider: A certificate of participation will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)

DISCLOSURE POLICY:  University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.

Mitigation of Relevant Financial Relationships

University of Iowa Roy J. and Lucille A. Carver College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all financial relationships with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships have been mitigated prior to the commencement of the activity.